Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06023225 · ClinicalTrials.gov registry record

Sex Hormones, Postoperative Pain and Opioid Use

A clinical trial of Postoperative Pain and Opioid Use, sponsored by Washington University School of Medicine.

Recruiting
Registry status
210
Enrollment target
1
Study location

NCT06023225: Recruiting study of Postoperative Pain and Opioid Use, sponsored by Washington University School of Medicine.

NCT06023225 is a study of Postoperative Pain and Opioid Use that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 210 participants, roughly in line with the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06023225, a study of Postoperative Pain and Opioid Use, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
210 participants
Enrollment target
1
Study location

Study Summary

Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors

Interventions

  • BEHAVIORAL Pain
  • BEHAVIORAL Opioid use

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2023-09-01
Est. Completion 2029-07-01

What NCT06023225 shows while recruiting

NCT06023225 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 230-participant average among 120 other Postoperative Pain trials with a reported enrollment target.

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Pain is the first listed.

NCT06023225 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06023225 about?

NCT06023225 is a clinical study titled "Sex Hormones, Postoperative Pain and Opioid Use". Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors

What is the current status of trial NCT06023225?

This trial is currently recruiting. The enrollment target is 210 participants. The study started on 2023-09-01. Estimated completion is 2029-07-01.

What conditions does trial NCT06023225 study?

This clinical trial studies the following conditions: Postoperative Pain, Opioid Use.

What interventions are being tested in trial NCT06023225?

The interventions under investigation include: Pain (BEHAVIORAL), Opioid use (BEHAVIORAL).

Who is sponsoring clinical trial NCT06023225?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06023225 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06023225's enrollment target sits among peer trials

210 30th of 120 higher than 91 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

  • NCT03544489 · 210 participants · Phase 2

    Effectiveness of Exercise After an ICD

  • NCT04408430 · 210 participants · NA

    The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06023225, the US trial registry maintained by the National Library of Medicine. NCT06023225 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.